Clinical Trial Update: ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ASTRAEA investigating a combination of myeloid inhibition and radiation in metastatic triple-negative breast cancer; study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Stephen Shiao | Conditions: TNBC - Triple-Negative Breast Cancer, Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING